You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 20, 2024

Investigational Drug Information for Hemay005


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Hemay005?

Hemay005 is an investigational drug.

There have been 12 clinical trials for Hemay005. The most recent clinical trial was a Phase 2 trial, which was initiated on November 15th 2023.

The most common disease conditions in clinical trials are Psoriasis, Behcet Syndrome, and Dermatitis. The leading clinical trial sponsors are Tianjin Hemay Pharmaceutical Co.,Ltd, Ganzhou Hemay Pharmaceutical Co., Ltd, and Tianjin Hemay Bio-Tech Co., Ltd.

There is one US patent protecting this investigational drug and seven international patents.

Recent Clinical Trials for Hemay005
TitleSponsorPhase
A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Beh├žet's DiseaseGanzhou Hemay Pharmaceutical Co., LtdPhase 3
A Study of Hemay005 in Adult With Atopic DermatitisGanzhou Hemay Pharmaceutical Co., LtdPhase 2
Phase II Study of Hemay005 in Patients With Active Ulcerative ColitisGanzhou Hemay Pharmaceutical Co., LtdPhase 2

See all Hemay005 clinical trials

Clinical Trial Summary for Hemay005

Top disease conditions for Hemay005
Top clinical trial sponsors for Hemay005

See all Hemay005 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.